The application and principle of Triptorelin(cas 57773-63-4)

Triptorelin(cas 57773-63-4) is also called triptorelin acetate injection. This drug is a synthetic gonadotropin-releasing hormone (GnRH) decapeptide congener, but its activity is stronger than natural GnRH, and it can promote luteinizing in human blood. The levels of LH, FSH, T and E2 have been adjusted to achieve various goals.


Triptorelin is often used clinically to treat patients who need to reduce steroid hormones such as male hormones and estrogen to low levels. It can also be used as a treatment for male prostate cancer. It is also common in the treatment of female infertility diseases. , Also has a certain reputation in the field of assisted reproduction.

This product is an analog of synthetic gonadotropin releasing hormone. The clinical effect is definite. It is the world’s first sustained-release gonadotropin releasing hormone analogue put on the market, and its activity is 100 times that of natural hormones.

The preparation has been on the market in more than 80 countries around the world, which fully proves that this product is safe and effective.

Studies have shown that this product can significantly improve the symptoms of dysmenorrhea, chronic pelvic pain and dyspareunia, and can reduce the focus of the disease and reduce the recurrence after surgery and increase the pregnancy rate after treatment.

The role of triptorelin

The principle of action of triptorelin is simple. The drug can strongly inhibit the secretion of gonadotropin, and its activity is stronger than natural GnRH. After the start of administration, the blood circulation of LH, FSH, testosterone and estradiol There will be transient peaks in treatments such as levels, and these indicators will continue to decline after continuous administration.